Loading...
SciDev Limited
SDV.AX•ASX
Basic Materials
Chemicals - Specialty
A$0.32
A$-0.01(-1.54%)
SciDev Limited (SDV.AX) Financial Performance & Statements
Review SciDev Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
21.76%
↑ 21.76%
Operating Income Growth
2614.04%
↑ 2614.04%
Net Income Growth
741.59%
↑ 741.59%
Operating Cash Flow Growth
34.61%
↑ 34.61%
Operating Margin
11.37%
↑ 11.37%
Gross Margin
32.04%
↑ 32.04%
Net Profit Margin
1.88%
↑ 1.88%
ROE
4.02%
↑ 4.02%
ROIC
22.54%
↑ 22.54%
SciDev Limited (SDV.AX) Financial Statements
Explore quarterly and annual reports for SciDev Limited stock.
Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
---|---|---|---|---|
Revenue | $58.96M | $50.19M | $40.25M | $49.47M |
Cost of Revenue | $40.23M | $45.52M | $37.51M | $45.38M |
Gross Profit | $18.73M | $4.67M | $2.74M | $4.09M |
Gross Profit Ratio | $0.32 | $0.09 | $0.07 | $0.08 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $11.41M | $3.58M | $3.33M | $3.05M |
Operating Expenses | $11.41M | $3.56M | $3.33M | $3.04M |
Total Costs & Expenses | $51.64M | $49.07M | $40.83M | $48.43M |
Interest Income | $0.00 | $0.00 | $80000.00 | $434000.00 |
Interest Expense | $349000.00 | $301000.00 | $196000.00 | $434000.00 |
Depreciation & Amortization | $1.44M | $2.04M | $2.02M | $1.49M |
EBITDA | $5.03M | $2.62M | $1.42M | $2.50M |
EBITDA Ratio | $0.09 | $0.06 | $0.04 | $0.05 |
Operating Income | $7.32M | $1.11M | -$587000.00 | $1.04M |
Operating Income Ratio | $0.12 | $0.02 | -$0.01 | $0.02 |
Other Income/Expenses (Net) | -$4.10M | -$229000.00 | -$203000.00 | -$474999.00 |
Income Before Tax | $3.22M | $886000.00 | -$790000.00 | $568000.00 |
Income Before Tax Ratio | $0.05 | $0.02 | -$0.02 | $0.01 |
Income Tax Expense | $1.10M | $829000.00 | -$424000.00 | $541000.00 |
Net Income | $2.12M | $57000.00 | -$366000.00 | $27000.00 |
Net Income Ratio | $0.04 | $0.001 | -$0.009 | $0.001 |
EPS | $0.01 | $0.00 | -$0.002 | $0.00 |
Diluted EPS | $0.01 | $0.00 | -$0.002 | $0.00 |
Weighted Avg Shares Outstanding | $189.85M | $189.85M | $189.85M | $189.52M |
Weighted Avg Shares Outstanding (Diluted) | $189.85M | $189.85M | $189.85M | $189.52M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan